Onyx Biotec Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	30.32	18.45	33.53
Depreciation & Amortization	22.49	14.91	14.48
Other Operating Activities	32.65	13.04	11.38
Change in Accounts Receivable	-102.97	33.42	-60
Change in Inventory	-27.74	-32.76	2.99
Change in Accounts Payable	68.63	26.06	30.08
Change in Other Net Operating Assets	-8.21	-10.75	-27.6
Operating Cash Flow	15.16	62.36	4.85
Operating Cash Flow Growth	-75.69%	1184.71%	-
Capital Expenditures	-32.23	-227.37	-57.86
Other Investing Activities	0.75	0.65	0.1
Investing Cash Flow	-31.48	-226.72	-57.76
Short-Term Debt Issued	-	75.99	24.79
Long-Term Debt Issued	55.75	93.86	32.34
Total Debt Issued	55.75	169.84	57.13
Short-Term Debt Repaid	-40.23	-	-
Total Debt Repaid	-40.23	-	-
Net Debt Issued (Repaid)	15.52	169.84	57.13
Issuance of Common Stock	36.46	-	-
Other Financing Activities	-21.07	-5.55	-5.15
Financing Cash Flow	30.91	164.3	51.98
Miscellaneous Cash Flow Adjustments	0	-42.83	0
Net Cash Flow	14.59	-42.9	-0.93
Free Cash Flow	-17.07	-165.01	-53
Free Cash Flow Margin	-3.17%	-41.78%	-11.82%
Free Cash Flow Per Share	-1.43	-13.98	-4.49
Cash Interest Paid	21.07	5.55	5.15
Levered Free Cash Flow	-56.18	-172.52	-
Unlevered Free Cash Flow	-43.01	-168.99	-
Change in Net Working Capital	71.17	-24.38	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.